Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease
Clinical trial NCT03257046 · COMPLETED
Trial details
- NCT number
- NCT03257046
- Sponsor
- Intra-Cellular Therapies, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-28
- Primary completion
- 2018-09-06
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.